Tower Research Capital LLC (TRC) - NLS PHARMACEUTICS LTD ownership

Back to all holdings Add to watchlist

NLS PHARMACEUTICS LTD's ticker is NLSP and the CUSIP is H57830103. A total of 6 filers reported holding NLS PHARMACEUTICS LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of NLS PHARMACEUTICS LTD
ValueSharesWeighting
Q2 2023$110–1000.0%0.00%–
Q4 2022$0
-100.0%
100
-97.3%
0.00%–
Q1 2022$5,000
-96.6%
3,665
-90.0%
0.00%
-100.0%
Q1 2021$148,000–36,525–0.00%–
 Download
Other shareholders
NLS PHARMACEUTICS LTD shareholders Q1 2022
NameSharesValueWeighting ↓
Tower Research Capital LLC (TRC) 36,525$148,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MILLENNIUM MANAGEMENT LLC 33,213$134,0000.00%
Clearstead Advisors, LLC 300$1,0000.00%
View complete list of NLS PHARMACEUTICS LTD shareholders